Pharmacological effects and safety of Andrographis paniculata (Burm.f.) Nees
© 2022 Institute of Food Technologists®..
Andrographis paniculata (Burm.f.) Nees (AP) is widely used in most Asian and some Western countries. However, its main effects and underlying pharmacological mechanism have not been thoroughly characterized, and its safety has not been sufficiently investigated. The present study aimed to predict and visualize the potential targets and pathways, clarify the main pharmacological effects, and investigate the toxicological properties of AP extract (APE). First, ingenuity pathway analysis (IPA) was performed to directly predict AP's therapeutic targets and pathways; main pharmacological effects of AP were speculated based on IPA results and confirmed by pharmacodynamics experiments. Rodent toxicity studies were then performed through administration of a single dose of 10 g/kg or daily doses of 2, 1, or 0.5 g/kg for 8 weeks to evaluate the safety of APE, and a similar repeated-dose study was performed using dogs with doses equal to half of the above-mentioned doses. Thus, repeated-dose toxicity studies were performed with both rodents and nonrodents. The IPA analysis and confirmatory pharmacodynamics experiments revealed that the main pharmacological effect of APE was anti-inflammation, which might be achieved by influencing various targets (e.g., AR, AKT, and BAX) and pathways (IL-8). In the single-dose toxicity test, no death or abnormal consequences were observed, and maximum tolerated dose of APE was 10 g/kg. Results from the repeated-dose toxicity tests did not reveal any obvious toxic effects from the repeated daily intragastric administration of APE at 1 g/kg for 8 weeks. In conclusion, APE at a dose of 1 g/kg did not exert any adverse effects, and administration of APE could be beneficial for the inflammatory diseases' treatment. PRACTICAL APPLICATION: Andrographis paniculata (Burm.f.) Nees is a plant that exerts clearing and detoxification effects and is widely used around the world, but a comprehensive analysis of its efficacy and safety is needed.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:87 |
---|---|
Enthalten in: |
Journal of food science - 87(2022), 3 vom: 19. März, Seite 1319-1330 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tian, Jingzhuo [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 04.03.2022 Date Revised 04.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/1750-3841.16079 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336984324 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM336984324 | ||
003 | DE-627 | ||
005 | 20231225233402.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/1750-3841.16079 |2 doi | |
028 | 5 | 2 | |a pubmed24n1123.xml |
035 | |a (DE-627)NLM336984324 | ||
035 | |a (NLM)35166368 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tian, Jingzhuo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pharmacological effects and safety of Andrographis paniculata (Burm.f.) Nees |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.03.2022 | ||
500 | |a Date Revised 04.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 Institute of Food Technologists®. | ||
520 | |a Andrographis paniculata (Burm.f.) Nees (AP) is widely used in most Asian and some Western countries. However, its main effects and underlying pharmacological mechanism have not been thoroughly characterized, and its safety has not been sufficiently investigated. The present study aimed to predict and visualize the potential targets and pathways, clarify the main pharmacological effects, and investigate the toxicological properties of AP extract (APE). First, ingenuity pathway analysis (IPA) was performed to directly predict AP's therapeutic targets and pathways; main pharmacological effects of AP were speculated based on IPA results and confirmed by pharmacodynamics experiments. Rodent toxicity studies were then performed through administration of a single dose of 10 g/kg or daily doses of 2, 1, or 0.5 g/kg for 8 weeks to evaluate the safety of APE, and a similar repeated-dose study was performed using dogs with doses equal to half of the above-mentioned doses. Thus, repeated-dose toxicity studies were performed with both rodents and nonrodents. The IPA analysis and confirmatory pharmacodynamics experiments revealed that the main pharmacological effect of APE was anti-inflammation, which might be achieved by influencing various targets (e.g., AR, AKT, and BAX) and pathways (IL-8). In the single-dose toxicity test, no death or abnormal consequences were observed, and maximum tolerated dose of APE was 10 g/kg. Results from the repeated-dose toxicity tests did not reveal any obvious toxic effects from the repeated daily intragastric administration of APE at 1 g/kg for 8 weeks. In conclusion, APE at a dose of 1 g/kg did not exert any adverse effects, and administration of APE could be beneficial for the inflammatory diseases' treatment. PRACTICAL APPLICATION: Andrographis paniculata (Burm.f.) Nees is a plant that exerts clearing and detoxification effects and is widely used around the world, but a comprehensive analysis of its efficacy and safety is needed | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a extract of Andrographis paniculata (Burm.f.) Nees | |
650 | 4 | |a ingenuity pathway analysis | |
650 | 4 | |a pharmacological effect | |
650 | 4 | |a repeated-dose toxicity study | |
650 | 4 | |a single-dose toxicity study | |
650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
650 | 7 | |a Plant Extracts |2 NLM | |
700 | 1 | |a Li, Chunying |e verfasserin |4 aut | |
700 | 1 | |a Meng, Jing |e verfasserin |4 aut | |
700 | 1 | |a Wang, Lianmei |e verfasserin |4 aut | |
700 | 1 | |a Tong, Yan |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Yong |e verfasserin |4 aut | |
700 | 1 | |a Yi, Yan |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yushi |e verfasserin |4 aut | |
700 | 1 | |a Xian, Zhong |e verfasserin |4 aut | |
700 | 1 | |a Pan, Chen |e verfasserin |4 aut | |
700 | 1 | |a Liu, Suyan |e verfasserin |4 aut | |
700 | 1 | |a Han, Jiayin |e verfasserin |4 aut | |
700 | 1 | |a Liang, Aihua |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of food science |d 1995 |g 87(2022), 3 vom: 19. März, Seite 1319-1330 |w (DE-627)NLM114360774 |x 1750-3841 |7 nnns |
773 | 1 | 8 | |g volume:87 |g year:2022 |g number:3 |g day:19 |g month:03 |g pages:1319-1330 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/1750-3841.16079 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 87 |j 2022 |e 3 |b 19 |c 03 |h 1319-1330 |